Grant Adams has taken a position at MacPhearson Pharmaceuticals for one reason: to get his daughter, recently diagnosed with bronchiosclerosis, into the country's only clinical trial testing a miraculous new drug to treat the fatal disease. In the multi-billion dollar pharmaceutical industry the primary objective is to develop marketable drugs but at what cost?
Read More
Grant Adams has taken a position at MacPhearson Pharmaceuticals for one reason: to get his daughter, recently diagnosed with bronchiosclerosis, into the country's only clinical trial testing a miraculous new drug to treat the fatal disease. In the multi-billion dollar pharmaceutical industry the primary objective is to develop marketable drugs but at what cost?
Read Less
Add this copy of Trials: the Risk/Benefit Ratio to cart. $10.00, very good condition, Sold by MLC Books rated 4.0 out of 5 stars, ships from Northfield, MN, UNITED STATES, published 2008 by Beaver's Pond Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very Good. No Jacket. Signed by Author Grant Adams takes a position at a pharmaceutical company to get his daughter into a clinical trial. When he is caught in a web of unethical science and murder he has to make a choice between exposing the evil and risking his daughter's life. First printing. Gently bumped and rubbed with a newspaper article about the authors and book taped in the back. Signed on the half title page by M. Smith and E. Smith.
Add this copy of Trials: the Risk/Benefit Ratio to cart. $37.76, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2007 by Beaver's Pond Press.
